Inflammatix Receives FDA Clearance For Blood Test To Help ER Clinicians Diagnose Infections, Sepsis

Inflammatix received US FDA clearance to market its TriVerity Test System to help emergency departments quickly triage patients suspected of having acute infection or sepsis. Medtech Insight spoke with Inflammatix CEO Tim Sweeney about the company’s business strategy and marketing plans.